American Association for Cancer Research

Noncoding RNAs and Cancer

Bookmark and Share


Noncoding RNAs and Cancer conferenceNoncoding RNAs and Cancer
January 8-11, 2012
Eden Roc Renaissance Beach Resort and Spa
Miami Beach, FL

Phillip A. Sharp, David H. Koch Institute for Integrative Cancer Research at MIT, Cambridge, MA

Carlo M. Croce, The Ohio State University Comprehensive Cancer Center, Columbus, OH
William C. Hahn, Dana-Farber Cancer Institute, Boston, MA
Jeannie T. Lee, Massachusetts General Hospital, Boston, MA
Eric N. Olson, University of Texas Southwestern Medical Center, Dallas, TX

This conference highlighted the basic biology of RNA regulation, the latest translational work on the role of noncoding RNAs in cancer initiation and progression, and the use of noncoding RNAs in the diagnosis and treatment of cancer. This was a follow-up to the AACR's 2007 noncoding RNAs conference held outside of Boston and featured sessions on long noncoding RNAs and their biology, chromatin modifications, miRNA biology, miRNA regulation in development and in cancer, RNA in cancer, and RNA therapeutics. In addition to the plenary talks and poster sessions, the conference opened with a keynote lecture on physiological and pathological functions of microRNAs by David Baltimore of the California Institute of Technology.

* Adobe Acrobat Reader required

Please visit the AACR Meetings & Workshops Calendar for a complete list of upcoming programs.